Ozempic doesn't just reduce weight. Research shows GLP-1s also changes how much people spend on food, and the types of food ...

GoodRx CEO Wendy Barnes outlined the company's priorities at the 2025 JP Morgan Healthcare Conference in San Francisco.

Hims & Hers Health (NYSE: HIMS) is coming off a fantastic year in 2024 when its share price skyrocketed 172%. Is Hims & Hers ...

Annual treatments worth £6,000: Prescription hydrofacial, £1,000; Morpheus8, £1,300; Profhilo, £1,200; Botox, £760; Belotero ...

Here's a wrap-up of news on medicines and clinical treatments, including a win for the AMA, and updates from the TGA, PBS, and MBS, as well as ...

Ozempic and Wegovy have become popular options for people looking to lose weight, but there are some risks and side effects ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 465.16% and ...

Veterinary toxicologists are warning clients about the dangers of accidental exposure to semaglutide weight loss medications ...

While weight loss is a common new year's resolution for workers in the U.S., 2025 may mark the year that building weight loss ...

The race is on for new drugs that suppress appetite, improve glucose regulation and can replace injections. But do they ...

A new generation of weight loss drugs has helped some people lose significant amounts of weight and improve their health.